FDA.reportPublic FDA data

{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 84 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32 MCG Titration Pack]

RxCUI
2602768
RxNorm name
{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 84 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32 MCG Titration Pack]
Display name
{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 84 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32 MCG Titration Pack]
Full name
{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 84 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32 MCG Titration Pack]
Term type
BPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ddc3d400-bcb3-4b09-aae2-0768b10a5b0f{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 84 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32 MCG Titration Pack]BPCK14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0fTyvaso DPI 16-32 MCG Titration PackSY14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0fTyvaso DPI 16-32 MCG Titration PackPSN14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120